Abstract
Understanding cultivar responses to a new herbicide is crucial to determining appropriate herbicide use and management practices. Florpyrauxifen-benzyl is a new rice herbicide developed to control troublesome weeds in rice production. Little research has been conducted to characterize rice cultivar responses to florpyrauxifen-benzyl, and thus, a field experiment was conducted at the Pine Tree Research Station (PTRS) in 2017 and 2018 and at the Rice Research and Extension Center (RREC) in 2018 to determine rice cultivar tolerance to florpyrauxifen-benzyl as influenced by herbicide rate, the addition of imazethapyr, and rice growth stage. Another experiment was conducted in 2018 at PTRS and RREC to assess crop response when florpyrauxifen-benzyl at different rates is applied with and without malathion, a known cytochrome P450 inhibitor. Three cultivars were evaluated in both experiments: a long-grain variety “CL111,” a medium-grain variety “CL272,” and a long-grain hybrid “CLXL745.” Injury in the first experiment was higher when florpyrauxifen-benzyl was applied at 60 g ae ha−1 than at the labeled rate of 30 g ha−1, with the most injury being 10% when averaged over growth stage at the time of application. Generally, applications made at the 3-leaf growth stage resulted in the most injury; however, this injury was at most 14%. Additionally, there was no reduction in grain yield for any cultivar, indicating florpyrauxifen-benzyl can be used safely in conjunction with imazethapyr in imidazolinone-resistant rice. In the second experiment, there was no more than 10% injury and no reduction in grain yield, with the addition of malathion not causing an increase in rice injury. Results from these experiments indicate florpyrauxifen-benzyl can be mixed with imazethapyr and the addition of malathion will not lead to increased risk for injury to rice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.